The Role of Hydrea in Drug-Resistant CML Treatment
Chronic Myeloid Leukemia (CML) has seen remarkable advancements with targeted therapies, but drug resistance remains a clinical challenge in some patients. In such complex cases, maintaining access through a trusted Hydrea supplier becomes essential to support supportive treatment strategies and effective blood count control during resistant phases of the disease. Understanding Drug-Resistant...
0 Comentários 0 Compartilhamentos 2293 Visualizações